[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341166-105":59,"doc-detail-341166-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ass1-inhibits-triple-negative-breast-cancer-by-regulating-phgdh-stability-and-de-novo-serine-synthesis","ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis","","ASS1 inhibits triple-negative breast cancer by directly binding to PHGDH, promoting its ubiquitination-mediated degradation and thereby suppressing de novo serine synthesis. Tumor suppressive effects of ASS1 require PHGDH, as PHGDH knockout abrogates ASS1-driven inhibition. ASS1 loss partially restores proliferation when serine and glycine are depleted, while ASS1 overexpression suppresses proliferation is reversed by exogenous serine and glycine. These findings support the ASS1/PHGDH serine synthesis pathway as a promising therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ass1-inhibits-triple-negative-breast-cancer-by-regulating-phgdh-stability-and-de-novo-serine-synthesis/341166/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ass1-inhibits-triple-negative-breast-cancer-by-regulating-phgdh-stability-and-de-novo-serine-synthesis/341166.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does ASS1 inhibit triple-negative breast cancer?","Question",{"text":112,"@type":113},"ASS1 directly binds PHGDH and promotes its ubiquitination-mediated degradation, which suppresses de novo serine synthesis and inhibits tumorigenesis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does PHGDH play in ASS1’s tumor suppressive effects?",{"text":117,"@type":113},"PHGDH knockout strongly abrogates the tumor suppressive effects of ASS1, indicating that PHGDH is required for ASS1-mediated inhibition.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does adding serine and glycine change the effect of ASS1 on cell proliferation?",{"text":121,"@type":113},"When serine and glycine are depleted, ASS1 knockout/knockdown partially rescues proliferation. The inhibitory effect of ASS1 overexpression on proliferation is restored by adding serine and glycine.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341166,1790183385,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis  \nWensong Luo 1,6, Zizheng Zou1,2,6, Yuan Nie 1, Junli Luo3, Zhengnan Ming1, Xiyuan Hu 1, Tiao Luo4, Min Ouyang5, Mingquan Liu 1  \nHuicheng Tang 1, Yuanzhu Xie 1, Kunjian Peng1, Ling Chen1, Jiang Zhou1 and Zhiyong Luo 1 ✉ ,  \n© The Author(s) 2024  \n\n|  | Argininosuccinate synthase (ASS1), a critical enzyme in the urea cycle, acts as a tumor suppressor in many cancers. To date, the anticancer mechanism of ASS1 has not been fully elucidated. Here, we found that phosphoglycerate dehydrogenase (PHGDH), a key rate-limiting enzyme in serine synthesis, is a pivotal protein that interacts with ASS1 . Our results showed that ASS1 directly binds to PHGDH and promotes its ubiquitination-mediated degradation to inhibit serine synthesis, consequently suppressing tumorigenesis. Importantly, the tumor suppressive effects of ASS1 were strongly abrogated by PHGDH knockout. In addition, ASS1 knockout and knockdown partially rescued cell proliferation when serine and glycine were depleted, while the inhibitory effect of ASS1 overexpression on cell proliferation was restored by the addition of serine and glycine. These ﬁndings unveil a novel role of |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| ASS1 and suggest that the ASS1/PHGDH serine synthesis pathway is a promising target for cancer therapy. |  |  |\n|  | Cell Death and Disease (2024)15:319; [https://doi.org/10.1038/s41419-024-06672-z](https://doi.org/10.1038/s41419-024-06672-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nBreast cancer, one of the most common causes of death of women, is a variable disease at the molecular level [1–3] . Among the types of this disease, triple-negative breast cancer (TNBC) is the most challenging to address, and is characterized by a high degree of malignancy, poor prognosis, high recurrence rate and easy development of distant metastases [4] . Although mastectomy and chemotherapy signiﬁcantly enhanced the survival of patients with triple-negative breast cancer, prevention and treatment will always be impeded without a full understanding of the potential underlying mechanisms and pathogenesis involved [2] . Therefore, further comprehensive and in-depth research into the mechanisms underlying the occurrence and development of this disease is urgently needed to identify new therapeutic targets and thereby increase the therapeutic efﬁcacy. ASS1 is a recognized rate-limiting enzyme in arginine synthesis that catalyzes the production of argininosuccinate. A lack of ASS1 expression or ASS1 downregulation is very common in cancer, including myxoﬁbrosarcomas, breast cancer, malignant melanoma, liver cancer, prostate cancer, pancreatic cancer, renal cancer, and osteosarcomas [5–8] . Several reports have shown that ASS1 is underexpressed in a range of tumors and functions as a tumor suppressor [5–13] . Furthermore, ASS1 is associated with chemoresistance, invasion, recurrence, and poor clinical outcomes, including breast cancer, HCC, renal cell carcinoma, and prostate cancer [10, 13, 14], in which ASS1 expression is lost [8, 10, 11] . Our  \nprevious work showed that increased activity of ASS1 induced by its activator exerts an anticancer function by reducing pyrimidine synthesis. However, the addition of pyrimidines only partially rescued cell viability, suggesting that there may be another antitumor pathway involving ASS1 [13] . Furthermore, the molecular pathways that are modulated by ASS1 are still not fully exhaustive, and its function in TNBC is even less well understood. Cell metabolic reprogramming is a well-recognized hallmark of cancer that exploits metabolites for rapid growth and proliferation [15, 16] . An important metabolic adaptation to the rapid proliferation of many human cancers is the increased biosynthesis of serine and glycine [17, 18] . Serine and gly","cbCaie4VB2jpXfV7","https://ap.wps.com/l/cbCaie4VB2jpXfV7","pdf",8459749,13,"English","# Introduction\n## Breast cancer and TNBC challenges\n## ASS1 as a tumor suppressor in multiple cancers\n## Cancer metabolic reprogramming and serine/glycine biosynthesis\n## PHGDH as the rate-limiting enzyme in the serine biosynthetic pathway\n## Rationale for targeting the ASS1/PHGDH pathway","[{\"question\":\"How does ASS1 inhibit triple-negative breast cancer?\",\"answer\":\"ASS1 directly binds PHGDH and promotes its ubiquitination-mediated degradation, which suppresses de novo serine synthesis and inhibits tumorigenesis.\"},{\"question\":\"What role does PHGDH play in ASS1’s tumor suppressive effects?\",\"answer\":\"PHGDH knockout strongly abrogates the tumor suppressive effects of ASS1, indicating that PHGDH is required for ASS1-mediated inhibition.\"},{\"question\":\"Why does adding serine and glycine change the effect of ASS1 on cell proliferation?\",\"answer\":\"When serine and glycine are depleted, ASS1 knockout/knockdown partially rescues proliferation. The inhibitory effect of ASS1 overexpression on proliferation is restored by adding serine and glycine.\"}]","ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis | PDF",1790040672,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ebd19281468c5ff1834ead8ff243c10.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/978795164aa5fee7429d57b991d7e34b.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73cdf7722dfff51c389e19251cdf30a9.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b271d39aafc446037c383212000f59d6.webp",980,1301]